Two New Nutritional Products Under Development at Schirmen Pharma
Schirmen Pharmaceuticals GmbH is coming up with two new nutritional products that are aimed at strengthening the immune system and lowering the symptoms related to degenerative disorders like osteoarthritis. These products are being developed at the company’s headquarters in Germany and will be distributed across the world through its distribution network.
Product aimed towards relieving pain in Osteoarthritis patients
Osteoarthritis is one of the most common forms of arthritis, affecting the crores of people across the world. This degenerative disorder can damage any joint; however, it commonly affects joints in your hands, knees, hips and spine. The most common symptoms of this disorder include joint pains, joint stiffness, and tenderness, loss of flexibility, grating sensation, bone spurs and swelling. The product under development will help the healing process, relieve pain and promote the overall health of the structural (Musculoskeletal) system among the arthritis patients.
Benefits of collagen in the diet
Collagen, one of the major ingredients the products under development, is composed of long-chain proteins, and when it is consumed the digestive system breaks down the proteins into amino acids. The amino acids are then absorbed and used as building blocks that support collagen production throughout the body and help heal the body from within. The supplement is also associated with improving skin health by reducing wrinkles and dryness. Collagen also increases muscle mass, prevent bone loss, and relieve joint pain.
Nutrient Product aimed at improving immunity system
Micronutrient deficiencies affect at least 2 billion people worldwide. The second product under development is aimed at addressing the health disorders arising from deficiency of Vitamins, Minerals and other nutrients. Deficiencies can lead to a variety of health problems. People suffering from lack of nutrients are more susceptible to digestion problems, skin disorders, stunted or defective bone growth, and even dementia. The product will help in improving appetite and ensure good health among the population.
Micronutrients – An important tool to fight disorders in developing countries
Infant mortality is another major cause of deaths in developing countries. Lack of micronutrients in the bearing mother is attributed as the main cause for it which leads to many complications like birth defects, premature birth, and death. Moreover, children and young adults who receive adequate nutrition are not as likely to die from diseases like diarrhoea, malaria, pneumonia, measles, HIV, anaemia, cancer, TB etc.
The development of these two nutritional products adds to the growing list of pharmaceutical products developed by the team at Schirmen Pharmaceuticals.